Genomic profiling of Chinese patients with urothelial carcinoma
Abstract Backgrounds Urothelial carcinoma (UC) is the most common genitourinary malignancy in China. In this study, we surveyed the genomic features in Chinese UC patients and investigated the concordance of genetic alterations between circulating tumor DNA (ctDNA) in plasma and matched tumor tissue...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-07829-1 |
id |
doaj-4b83bb4748b742f2ad8c8cd3d10b6dbc |
---|---|
record_format |
Article |
spelling |
doaj-4b83bb4748b742f2ad8c8cd3d10b6dbc2021-02-21T12:47:19ZengBMCBMC Cancer1471-24072021-02-0121111110.1186/s12885-021-07829-1Genomic profiling of Chinese patients with urothelial carcinomaBo Yang0Xiao Zhao1Chong Wan2Xin Ma3Shaoxi Niu4Aitao Guo5Jieli Wang6Jinliang Wang7Decong Sun8Shunchang Jiao9Department of Oncology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalLifehealthcare Clinical LaboratoriesDepartment of Urology, Chinese PLA General HospitalDepartment of Urology, Chinese PLA General HospitalDepartment of Pathology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalDepartment of Oncology, Chinese PLA General HospitalAbstract Backgrounds Urothelial carcinoma (UC) is the most common genitourinary malignancy in China. In this study, we surveyed the genomic features in Chinese UC patients and investigated the concordance of genetic alterations between circulating tumor DNA (ctDNA) in plasma and matched tumor tissue. Materials and methods A total of 112 UC patients were enrolled, of which 31 were upper tract UC (UTUC) and 81 were UC of bladder (UCB). Genomic alterations in 92 selected genes were analyzed by targeted next-generation sequencing. Results In the study cohort, 94.64, 86.61 and 62.50% of patients were identified as having valid somatic, oncogenic and actionable somatic alterations, respectively. The most frequently altered genes included TP53, KMT2D, KDM6A, FAT4, FAT1, CREBBP and ARID1A. The higher prevalence of HRAS (22.0% vs 3.7%) and KMT2D (59.26% vs 34.57%) was identified in UTUC than in UCB. Comparisons of somatic alterations of UCB and UTUC between the study cohort and western cohorts revealed significant differences in mutant prevalence. Notably, 28.57, 17.86 and 47.32% of the cases harbored alterations in FGFRs, ERBBs and DNA damage repair genes, respectively. Furthermore, 75% of the patients carried non-benign germline variants, but only two (1.79%) were pathogenic. The overall concordance for genomic alterations in ctDNA and matched tumor tissue was 42.97% (0–100%). Notably, 47.25% of alterations detected in ctDNA were not detected in the matched tissue, and 54.14% of which were oncogenic mutations. Conclusions We found a unique genomic feature of Chinese UC patients. A reasonably good concordance of genomic features between ctDNA and tissue samples were identified.https://doi.org/10.1186/s12885-021-07829-1Urothelial carcinomaGenomic alterationsctDNA |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bo Yang Xiao Zhao Chong Wan Xin Ma Shaoxi Niu Aitao Guo Jieli Wang Jinliang Wang Decong Sun Shunchang Jiao |
spellingShingle |
Bo Yang Xiao Zhao Chong Wan Xin Ma Shaoxi Niu Aitao Guo Jieli Wang Jinliang Wang Decong Sun Shunchang Jiao Genomic profiling of Chinese patients with urothelial carcinoma BMC Cancer Urothelial carcinoma Genomic alterations ctDNA |
author_facet |
Bo Yang Xiao Zhao Chong Wan Xin Ma Shaoxi Niu Aitao Guo Jieli Wang Jinliang Wang Decong Sun Shunchang Jiao |
author_sort |
Bo Yang |
title |
Genomic profiling of Chinese patients with urothelial carcinoma |
title_short |
Genomic profiling of Chinese patients with urothelial carcinoma |
title_full |
Genomic profiling of Chinese patients with urothelial carcinoma |
title_fullStr |
Genomic profiling of Chinese patients with urothelial carcinoma |
title_full_unstemmed |
Genomic profiling of Chinese patients with urothelial carcinoma |
title_sort |
genomic profiling of chinese patients with urothelial carcinoma |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2021-02-01 |
description |
Abstract Backgrounds Urothelial carcinoma (UC) is the most common genitourinary malignancy in China. In this study, we surveyed the genomic features in Chinese UC patients and investigated the concordance of genetic alterations between circulating tumor DNA (ctDNA) in plasma and matched tumor tissue. Materials and methods A total of 112 UC patients were enrolled, of which 31 were upper tract UC (UTUC) and 81 were UC of bladder (UCB). Genomic alterations in 92 selected genes were analyzed by targeted next-generation sequencing. Results In the study cohort, 94.64, 86.61 and 62.50% of patients were identified as having valid somatic, oncogenic and actionable somatic alterations, respectively. The most frequently altered genes included TP53, KMT2D, KDM6A, FAT4, FAT1, CREBBP and ARID1A. The higher prevalence of HRAS (22.0% vs 3.7%) and KMT2D (59.26% vs 34.57%) was identified in UTUC than in UCB. Comparisons of somatic alterations of UCB and UTUC between the study cohort and western cohorts revealed significant differences in mutant prevalence. Notably, 28.57, 17.86 and 47.32% of the cases harbored alterations in FGFRs, ERBBs and DNA damage repair genes, respectively. Furthermore, 75% of the patients carried non-benign germline variants, but only two (1.79%) were pathogenic. The overall concordance for genomic alterations in ctDNA and matched tumor tissue was 42.97% (0–100%). Notably, 47.25% of alterations detected in ctDNA were not detected in the matched tissue, and 54.14% of which were oncogenic mutations. Conclusions We found a unique genomic feature of Chinese UC patients. A reasonably good concordance of genomic features between ctDNA and tissue samples were identified. |
topic |
Urothelial carcinoma Genomic alterations ctDNA |
url |
https://doi.org/10.1186/s12885-021-07829-1 |
work_keys_str_mv |
AT boyang genomicprofilingofchinesepatientswithurothelialcarcinoma AT xiaozhao genomicprofilingofchinesepatientswithurothelialcarcinoma AT chongwan genomicprofilingofchinesepatientswithurothelialcarcinoma AT xinma genomicprofilingofchinesepatientswithurothelialcarcinoma AT shaoxiniu genomicprofilingofchinesepatientswithurothelialcarcinoma AT aitaoguo genomicprofilingofchinesepatientswithurothelialcarcinoma AT jieliwang genomicprofilingofchinesepatientswithurothelialcarcinoma AT jinliangwang genomicprofilingofchinesepatientswithurothelialcarcinoma AT decongsun genomicprofilingofchinesepatientswithurothelialcarcinoma AT shunchangjiao genomicprofilingofchinesepatientswithurothelialcarcinoma |
_version_ |
1724257684036780032 |